Gamma surgery in the treatment of nonsecretory pituitary macroadenoma
- 1 June 2006
- journal article
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 104 (6), 876-883
- https://doi.org/10.3171/jns.2006.104.6.876
Abstract
The authors report on a retrospective analysis of the imaging and clinical outcomes following gamma surgery in 100 patients with nonsecretory pituitary macroadenoma. Between June 1989 and March 2004, 100 consecutive patients with nonsecretory pituitary macroadenoma were treated at the Lars Leksell Center for Gamma Surgery, University of Virginia Health System (Charlottesville, VA). Ninety-two patients had residual or recurrent macroadenoma following one or more surgical procedures. In eight patients, gamma surgery was the primary treatment. Ten patients received conventional fractionated radiotherapy before the gamma surgery. Sixty-nine patients required hormone replacement therapy for one or more deficits before gamma knife treatment. Peripheral doses between 5 and 25 Gy (mean 18.5 Gy) were administered. Imaging and endocrinological follow-up evaluations were performed in 90 patients; these studies ranged from 6 to 142 months (mean 44.9 months) and 6 to 127 months (mean 47.9 months), respectively. Tumor volume decreased in 59 patients (65.6%), remained unchanged in 24 (26.7%), and increased in seven (7.8%). The minimal effective peripheral dose was 12 Gy; peripheral doses greater than 20 Gy did not seem to provide additional benefit. Of 61 patients with a partially or fully functioning pituitary gland and follow-up data, 12 (19.7%) suffered new hormone deficits following gamma surgery. In patients with endocrinological follow-up data that had been collected over more than 2 years, the rate of new deficits was 25%. No neurological morbidity or death was related to treatment. Current experience suggests that gamma surgery is an appropriate means of managing recurrent or residual nonsecretory pituitary macroadenoma following microsurgery and a primary treatment in selected patients. To evaluate definite rates of recurrence and new endocrine deficiencies, long-term follow-up studies are needed.Keywords
This publication has 56 references indexed in Scilit:
- Radiotherapy for non‐functioning pituitary tumoursClinical Endocrinology, 1998
- Transcranial Epidural Approach to Pituitary Tumors Extending beyond the SellaNeurosurgery, 1997
- Radiation therapy for pituitary adenoma: Treatment outcome and prognostic factorsInternational Journal of Radiation Oncology*Biology*Physics, 1994
- The Effects of Gamma Knife Surgery of Pituitary Adenomas on Tumor Growth and EndocrinopathiesStereotactic and Functional Neurosurgery, 1993
- Stereotactic radiosurgery with the cobalt-60 gamma unit in the treatment of growth hormone-producing pituitary tumorsNeurosurgery, 1991
- Stereotactic Radiosurgery with the Cobalt-60 Gamma Unit in the Treatment of Growth Hormone-Producing Pituitary TumorsNeurosurgery, 1991
- A combined orbitozygomatic infratemporal epidural and subdural approach for lesions involving the entire cavernous sinusJournal of Neurosurgery, 1989
- Surgery of tumors invading the cavernous sinusSurgical Neurology, 1988
- Transsphenoidal surgery following unsuccessful prior therapyJournal of Neurosurgery, 1985
- Transsphenoidal microsurgery of pituitary macroadenomas with long-term follow-up resultsJournal of Neurosurgery, 1983